ArticleDiscover oncology2025

Pan cohort immune biomarker of CD8 lymphocyte activation enabling HGSOC outcome prediction and treatment response.

Xinkui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.